Global Opioids Agonist Drugs Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Opioids Agonist Drugs Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Opioids Agonist Drugs by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Opioids Agonist Drugs by Country/Region, 2017, 2022 & 2028

2.2 Opioids Agonist Drugs Segment by Type

2.2.1 Codeine

2.2.2 Fentanyl

2.2.3 Meperidine

2.2.4 Methadone

2.2.5 Morphine

2.2.6 Hydrocodone

2.3 Opioids Agonist Drugs Sales by Type

2.3.1 Global Opioids Agonist Drugs Sales Market Share by Type (2017-2022)

2.3.2 Global Opioids Agonist Drugs Revenue and Market Share by Type (2017-2022)

2.3.3 Global Opioids Agonist Drugs Sale Price by Type (2017-2022)

2.4 Opioids Agonist Drugs Segment by Application

2.4.1 Pain Management

2.4.2 Cough Treatment

2.4.3 Diarrhea Treatment

2.5 Opioids Agonist Drugs Sales by Application

2.5.1 Global Opioids Agonist Drugs Sale Market Share by Application (2017-2022)

2.5.2 Global Opioids Agonist Drugs Revenue and Market Share by Application (2017-2022)

2.5.3 Global Opioids Agonist Drugs Sale Price by Application (2017-2022)

3 Global Opioids Agonist Drugs by Company

3.1 Global Opioids Agonist Drugs Breakdown Data by Company

3.1.1 Global Opioids Agonist Drugs Annual Sales by Company (2020-2022)

3.1.2 Global Opioids Agonist Drugs Sales Market Share by Company (2020-2022)

3.2 Global Opioids Agonist Drugs Annual Revenue by Company (2020-2022)

3.2.1 Global Opioids Agonist Drugs Revenue by Company (2020-2022)

3.2.2 Global Opioids Agonist Drugs Revenue Market Share by Company (2020-2022)

3.3 Global Opioids Agonist Drugs Sale Price by Company

3.4 Key Manufacturers Opioids Agonist Drugs Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Opioids Agonist Drugs Product Location Distribution

3.4.2 Players Opioids Agonist Drugs Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Opioids Agonist Drugs by Geographic Region

4.1 World Historic Opioids Agonist Drugs Market Size by Geographic Region (2017-2022)

4.1.1 Global Opioids Agonist Drugs Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Opioids Agonist Drugs Annual Revenue by Geographic Region

4.2 World Historic Opioids Agonist Drugs Market Size by Country/Region (2017-2022)

4.2.1 Global Opioids Agonist Drugs Annual Sales by Country/Region (2017-2022)

4.2.2 Global Opioids Agonist Drugs Annual Revenue by Country/Region

4.3 Americas Opioids Agonist Drugs Sales Growth

4.4 APAC Opioids Agonist Drugs Sales Growth

4.5 Europe Opioids Agonist Drugs Sales Growth

4.6 Middle East & Africa Opioids Agonist Drugs Sales Growth

5 Americas

5.1 Americas Opioids Agonist Drugs Sales by Country

5.1.1 Americas Opioids Agonist Drugs Sales by Country (2017-2022)

5.1.2 Americas Opioids Agonist Drugs Revenue by Country (2017-2022)

5.2 Americas Opioids Agonist Drugs Sales by Type

5.3 Americas Opioids Agonist Drugs Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Opioids Agonist Drugs Sales by Region

6.1.1 APAC Opioids Agonist Drugs Sales by Region (2017-2022)

6.1.2 APAC Opioids Agonist Drugs Revenue by Region (2017-2022)

6.2 APAC Opioids Agonist Drugs Sales by Type

6.3 APAC Opioids Agonist Drugs Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Opioids Agonist Drugs by Country

7.1.1 Europe Opioids Agonist Drugs Sales by Country (2017-2022)

7.1.2 Europe Opioids Agonist Drugs Revenue by Country (2017-2022)

7.2 Europe Opioids Agonist Drugs Sales by Type

7.3 Europe Opioids Agonist Drugs Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Opioids Agonist Drugs by Country

8.1.1 Middle East & Africa Opioids Agonist Drugs Sales by Country (2017-2022)

8.1.2 Middle East & Africa Opioids Agonist Drugs Revenue by Country (2017-2022)

8.2 Middle East & Africa Opioids Agonist Drugs Sales by Type

8.3 Middle East & Africa Opioids Agonist Drugs Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Opioids Agonist Drugs

10.3 Manufacturing Process Analysis of Opioids Agonist Drugs

10.4 Industry Chain Structure of Opioids Agonist Drugs

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Opioids Agonist Drugs Distributors

11.3 Opioids Agonist Drugs Customer

12 World Forecast Review for Opioids Agonist Drugs by Geographic Region

12.1 Global Opioids Agonist Drugs Market Size Forecast by Region

12.1.1 Global Opioids Agonist Drugs Forecast by Region (2023-2028)

12.1.2 Global Opioids Agonist Drugs Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Opioids Agonist Drugs Forecast by Type

12.7 Global Opioids Agonist Drugs Forecast by Application

13 Key Players Analysis

13.1 Purdue Pharma

13.1.1 Purdue Pharma Company Information

13.1.2 Purdue Pharma Opioids Agonist Drugs Product Offered

13.1.3 Purdue Pharma Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Purdue Pharma Main Business Overview

13.1.5 Purdue Pharma Latest Developments

13.2 Titan pharmaceuticals

13.2.1 Titan pharmaceuticals Company Information

13.2.2 Titan pharmaceuticals Opioids Agonist Drugs Product Offered

13.2.3 Titan pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Titan pharmaceuticals Main Business Overview

13.2.5 Titan pharmaceuticals Latest Developments

13.3 Boehringer Ingelheim

13.3.1 Boehringer Ingelheim Company Information

13.3.2 Boehringer Ingelheim Opioids Agonist Drugs Product Offered

13.3.3 Boehringer Ingelheim Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Boehringer Ingelheim Main Business Overview

13.3.5 Boehringer Ingelheim Latest Developments

13.4 Janssen Pharmaceuticals, Inc

13.4.1 Janssen Pharmaceuticals, Inc Company Information

13.4.2 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Offered

13.4.3 Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Janssen Pharmaceuticals, Inc Main Business Overview

13.4.5 Janssen Pharmaceuticals, Inc Latest Developments

13.5 Sanofi

13.5.1 Sanofi Company Information

13.5.2 Sanofi Opioids Agonist Drugs Product Offered

13.5.3 Sanofi Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 Sanofi Main Business Overview

13.5.5 Sanofi Latest Developments

13.6 Sun Pharmaceuticals

13.6.1 Sun Pharmaceuticals Company Information

13.6.2 Sun Pharmaceuticals Opioids Agonist Drugs Product Offered

13.6.3 Sun Pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Sun Pharmaceuticals Main Business Overview

13.6.5 Sun Pharmaceuticals Latest Developments

13.7 Mallinckrodt Pharmaceuticals

13.7.1 Mallinckrodt Pharmaceuticals Company Information

13.7.2 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Offered

13.7.3 Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Mallinckrodt Pharmaceuticals Main Business Overview

13.7.5 Mallinckrodt Pharmaceuticals Latest Developments

13.8 Egalet Corporation

13.8.1 Egalet Corporation Company Information

13.8.2 Egalet Corporation Opioids Agonist Drugs Product Offered

13.8.3 Egalet Corporation Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Egalet Corporation Main Business Overview

13.8.5 Egalet Corporation Latest Developments

13.9 Endo Pharmaceuticals Inc.

13.9.1 Endo Pharmaceuticals Inc. Company Information

13.9.2 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Offered

13.9.3 Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Endo Pharmaceuticals Inc. Main Business Overview

13.9.5 Endo Pharmaceuticals Inc. Latest Developments

13.10 Allergan, Plc

13.10.1 Allergan, Plc Company Information

13.10.2 Allergan, Plc Opioids Agonist Drugs Product Offered

13.10.3 Allergan, Plc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Allergan, Plc Main Business Overview

13.10.5 Allergan, Plc Latest Developments

13.11 Pfizer Inc

13.11.1 Pfizer Inc Company Information

13.11.2 Pfizer Inc Opioids Agonist Drugs Product Offered

13.11.3 Pfizer Inc Opioids Agonist Drugs Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Pfizer Inc Main Business Overview

13.11.5 Pfizer Inc Latest Developments

14 Research Findings and Conclusion

Table 1. Opioids Agonist Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Opioids Agonist Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Codeine

Table 4. Major Players of Fentanyl

Table 5. Major Players of Meperidine

Table 6. Major Players of Methadone

Table 7. Major Players of Morphine

Table 8. Major Players of Hydrocodone

Table 9. Global Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)

Table 10. Global Opioids Agonist Drugs Sales Market Share by Type (2017-2022)

Table 11. Global Opioids Agonist Drugs Revenue by Type (2017-2022) & ($ million)

Table 12. Global Opioids Agonist Drugs Revenue Market Share by Type (2017-2022)

Table 13. Global Opioids Agonist Drugs Sale Price by Type (2017-2022) & (USD/Unit)

Table 14. Global Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)

Table 15. Global Opioids Agonist Drugs Sales Market Share by Application (2017-2022)

Table 16. Global Opioids Agonist Drugs Revenue by Application (2017-2022)

Table 17. Global Opioids Agonist Drugs Revenue Market Share by Application (2017-2022)

Table 18. Global Opioids Agonist Drugs Sale Price by Application (2017-2022) & (USD/Unit)

Table 19. Global Opioids Agonist Drugs Sales by Company (2020-2022) & (K Units)

Table 20. Global Opioids Agonist Drugs Sales Market Share by Company (2020-2022)

Table 21. Global Opioids Agonist Drugs Revenue by Company (2020-2022) ($ Millions)

Table 22. Global Opioids Agonist Drugs Revenue Market Share by Company (2020-2022)

Table 23. Global Opioids Agonist Drugs Sale Price by Company (2020-2022) & (USD/Unit)

Table 24. Key Manufacturers Opioids Agonist Drugs Producing Area Distribution and Sales Area

Table 25. Players Opioids Agonist Drugs Products Offered

Table 26. Opioids Agonist Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 27. New Products and Potential Entrants

Table 28. Mergers & Acquisitions, Expansion

Table 29. Global Opioids Agonist Drugs Sales by Geographic Region (2017-2022) & (K Units)

Table 30. Global Opioids Agonist Drugs Sales Market Share Geographic Region (2017-2022)

Table 31. Global Opioids Agonist Drugs Revenue by Geographic Region (2017-2022) & ($ millions)

Table 32. Global Opioids Agonist Drugs Revenue Market Share by Geographic Region (2017-2022)

Table 33. Global Opioids Agonist Drugs Sales by Country/Region (2017-2022) & (K Units)

Table 34. Global Opioids Agonist Drugs Sales Market Share by Country/Region (2017-2022)

Table 35. Global Opioids Agonist Drugs Revenue by Country/Region (2017-2022) & ($ millions)

Table 36. Global Opioids Agonist Drugs Revenue Market Share by Country/Region (2017-2022)

Table 37. Americas Opioids Agonist Drugs Sales by Country (2017-2022) & (K Units)

Table 38. Americas Opioids Agonist Drugs Sales Market Share by Country (2017-2022)

Table 39. Americas Opioids Agonist Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 40. Americas Opioids Agonist Drugs Revenue Market Share by Country (2017-2022)

Table 41. Americas Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)

Table 42. Americas Opioids Agonist Drugs Sales Market Share by Type (2017-2022)

Table 43. Americas Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)

Table 44. Americas Opioids Agonist Drugs Sales Market Share by Application (2017-2022)

Table 45. APAC Opioids Agonist Drugs Sales by Region (2017-2022) & (K Units)

Table 46. APAC Opioids Agonist Drugs Sales Market Share by Region (2017-2022)

Table 47. APAC Opioids Agonist Drugs Revenue by Region (2017-2022) & ($ Millions)

Table 48. APAC Opioids Agonist Drugs Revenue Market Share by Region (2017-2022)

Table 49. APAC Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)

Table 50. APAC Opioids Agonist Drugs Sales Market Share by Type (2017-2022)

Table 51. APAC Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)

Table 52. APAC Opioids Agonist Drugs Sales Market Share by Application (2017-2022)

Table 53. Europe Opioids Agonist Drugs Sales by Country (2017-2022) & (K Units)

Table 54. Europe Opioids Agonist Drugs Sales Market Share by Country (2017-2022)

Table 55. Europe Opioids Agonist Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 56. Europe Opioids Agonist Drugs Revenue Market Share by Country (2017-2022)

Table 57. Europe Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)

Table 58. Europe Opioids Agonist Drugs Sales Market Share by Type (2017-2022)

Table 59. Europe Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)

Table 60. Europe Opioids Agonist Drugs Sales Market Share by Application (2017-2022)

Table 61. Middle East & Africa Opioids Agonist Drugs Sales by Country (2017-2022) & (K Units)

Table 62. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Country (2017-2022)

Table 63. Middle East & Africa Opioids Agonist Drugs Revenue by Country (2017-2022) & ($ Millions)

Table 64. Middle East & Africa Opioids Agonist Drugs Revenue Market Share by Country (2017-2022)

Table 65. Middle East & Africa Opioids Agonist Drugs Sales by Type (2017-2022) & (K Units)

Table 66. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Type (2017-2022)

Table 67. Middle East & Africa Opioids Agonist Drugs Sales by Application (2017-2022) & (K Units)

Table 68. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Application (2017-2022)

Table 69. Key Market Drivers & Growth Opportunities of Opioids Agonist Drugs

Table 70. Key Market Challenges & Risks of Opioids Agonist Drugs

Table 71. Key Industry Trends of Opioids Agonist Drugs

Table 72. Opioids Agonist Drugs Raw Material

Table 73. Key Suppliers of Raw Materials

Table 74. Opioids Agonist Drugs Distributors List

Table 75. Opioids Agonist Drugs Customer List

Table 76. Global Opioids Agonist Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 77. Global Opioids Agonist Drugs Sales Market Forecast by Region

Table 78. Global Opioids Agonist Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 79. Global Opioids Agonist Drugs Revenue Market Share Forecast by Region (2023-2028)

Table 80. Americas Opioids Agonist Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 81. Americas Opioids Agonist Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. APAC Opioids Agonist Drugs Sales Forecast by Region (2023-2028) & (K Units)

Table 83. APAC Opioids Agonist Drugs Revenue Forecast by Region (2023-2028) & ($ millions)

Table 84. Europe Opioids Agonist Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 85. Europe Opioids Agonist Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 86. Middle East & Africa Opioids Agonist Drugs Sales Forecast by Country (2023-2028) & (K Units)

Table 87. Middle East & Africa Opioids Agonist Drugs Revenue Forecast by Country (2023-2028) & ($ millions)

Table 88. Global Opioids Agonist Drugs Sales Forecast by Type (2023-2028) & (K Units)

Table 89. Global Opioids Agonist Drugs Sales Market Share Forecast by Type (2023-2028)

Table 90. Global Opioids Agonist Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 91. Global Opioids Agonist Drugs Revenue Market Share Forecast by Type (2023-2028)

Table 92. Global Opioids Agonist Drugs Sales Forecast by Application (2023-2028) & (K Units)

Table 93. Global Opioids Agonist Drugs Sales Market Share Forecast by Application (2023-2028)

Table 94. Global Opioids Agonist Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 95. Global Opioids Agonist Drugs Revenue Market Share Forecast by Application (2023-2028)

Table 96. Purdue Pharma Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 97. Purdue Pharma Opioids Agonist Drugs Product Offered

Table 98. Purdue Pharma Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 99. Purdue Pharma Main Business

Table 100. Purdue Pharma Latest Developments

Table 101. Titan pharmaceuticals Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 102. Titan pharmaceuticals Opioids Agonist Drugs Product Offered

Table 103. Titan pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 104. Titan pharmaceuticals Main Business

Table 105. Titan pharmaceuticals Latest Developments

Table 106. Boehringer Ingelheim Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 107. Boehringer Ingelheim Opioids Agonist Drugs Product Offered

Table 108. Boehringer Ingelheim Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 109. Boehringer Ingelheim Main Business

Table 110. Boehringer Ingelheim Latest Developments

Table 111. Janssen Pharmaceuticals, Inc Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 112. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Product Offered

Table 113. Janssen Pharmaceuticals, Inc Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 114. Janssen Pharmaceuticals, Inc Main Business

Table 115. Janssen Pharmaceuticals, Inc Latest Developments

Table 116. Sanofi Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 117. Sanofi Opioids Agonist Drugs Product Offered

Table 118. Sanofi Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 119. Sanofi Main Business

Table 120. Sanofi Latest Developments

Table 121. Sun Pharmaceuticals Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 122. Sun Pharmaceuticals Opioids Agonist Drugs Product Offered

Table 123. Sun Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 124. Sun Pharmaceuticals Main Business

Table 125. Sun Pharmaceuticals Latest Developments

Table 126. Mallinckrodt Pharmaceuticals Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 127. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Product Offered

Table 128. Mallinckrodt Pharmaceuticals Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 129. Mallinckrodt Pharmaceuticals Main Business

Table 130. Mallinckrodt Pharmaceuticals Latest Developments

Table 131. Egalet Corporation Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 132. Egalet Corporation Opioids Agonist Drugs Product Offered

Table 133. Egalet Corporation Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 134. Egalet Corporation Main Business

Table 135. Egalet Corporation Latest Developments

Table 136. Endo Pharmaceuticals Inc. Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 137. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Product Offered

Table 138. Endo Pharmaceuticals Inc. Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 139. Endo Pharmaceuticals Inc. Main Business

Table 140. Endo Pharmaceuticals Inc. Latest Developments

Table 141. Allergan, Plc Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 142. Allergan, Plc Opioids Agonist Drugs Product Offered

Table 143. Allergan, Plc Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 144. Allergan, Plc Main Business

Table 145. Allergan, Plc Latest Developments

Table 146. Pfizer Inc Basic Information, Opioids Agonist Drugs Manufacturing Base, Sales Area and Its Competitors

Table 147. Pfizer Inc Opioids Agonist Drugs Product Offered

Table 148. Pfizer Inc Opioids Agonist Drugs Sales (K Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2020-2022)

Table 149. Pfizer Inc Main Business

Table 150. Pfizer Inc Latest Developments

List of Figures

Figure 1. Picture of Opioids Agonist Drugs

Figure 2. Opioids Agonist Drugs Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Opioids Agonist Drugs Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global Opioids Agonist Drugs Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Opioids Agonist Drugs Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Codeine

Figure 10. Product Picture of Fentanyl

Figure 11. Product Picture of Meperidine

Figure 12. Product Picture of Methadone

Figure 13. Product Picture of Morphine

Figure 14. Product Picture of Hydrocodone

Figure 15. Global Opioids Agonist Drugs Sales Market Share by Type in 2021

Figure 16. Global Opioids Agonist Drugs Revenue Market Share by Type (2017-2022)

Figure 17. Opioids Agonist Drugs Consumed in Pain Management

Figure 18. Global Opioids Agonist Drugs Market: Pain Management (2017-2022) & (K Units)

Figure 19. Opioids Agonist Drugs Consumed in Cough Treatment

Figure 20. Global Opioids Agonist Drugs Market: Cough Treatment (2017-2022) & (K Units)

Figure 21. Opioids Agonist Drugs Consumed in Diarrhea Treatment

Figure 22. Global Opioids Agonist Drugs Market: Diarrhea Treatment (2017-2022) & (K Units)

Figure 23. Global Opioids Agonist Drugs Sales Market Share by Application (2017-2022)

Figure 24. Global Opioids Agonist Drugs Revenue Market Share by Application in 2021

Figure 25. Opioids Agonist Drugs Revenue Market by Company in 2021 ($ Million)

Figure 26. Global Opioids Agonist Drugs Revenue Market Share by Company in 2021

Figure 27. Global Opioids Agonist Drugs Sales Market Share by Geographic Region (2017-2022)

Figure 28. Global Opioids Agonist Drugs Revenue Market Share by Geographic Region in 2021

Figure 29. Global Opioids Agonist Drugs Sales Market Share by Region (2017-2022)

Figure 30. Global Opioids Agonist Drugs Revenue Market Share by Country/Region in 2021

Figure 31. Americas Opioids Agonist Drugs Sales 2017-2022 (K Units)

Figure 32. Americas Opioids Agonist Drugs Revenue 2017-2022 ($ Millions)

Figure 33. APAC Opioids Agonist Drugs Sales 2017-2022 (K Units)

Figure 34. APAC Opioids Agonist Drugs Revenue 2017-2022 ($ Millions)

Figure 35. Europe Opioids Agonist Drugs Sales 2017-2022 (K Units)

Figure 36. Europe Opioids Agonist Drugs Revenue 2017-2022 ($ Millions)

Figure 37. Middle East & Africa Opioids Agonist Drugs Sales 2017-2022 (K Units)

Figure 38. Middle East & Africa Opioids Agonist Drugs Revenue 2017-2022 ($ Millions)

Figure 39. Americas Opioids Agonist Drugs Sales Market Share by Country in 2021

Figure 40. Americas Opioids Agonist Drugs Revenue Market Share by Country in 2021

Figure 41. United States Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 42. Canada Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 43. Mexico Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 44. Brazil Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 45. APAC Opioids Agonist Drugs Sales Market Share by Region in 2021

Figure 46. APAC Opioids Agonist Drugs Revenue Market Share by Regions in 2021

Figure 47. China Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 48. Japan Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 49. South Korea Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 50. Southeast Asia Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 51. India Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 52. Australia Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 53. Europe Opioids Agonist Drugs Sales Market Share by Country in 2021

Figure 54. Europe Opioids Agonist Drugs Revenue Market Share by Country in 2021

Figure 55. Germany Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 56. France Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 57. UK Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 58. Italy Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 59. Russia Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 60. Middle East & Africa Opioids Agonist Drugs Sales Market Share by Country in 2021

Figure 61. Middle East & Africa Opioids Agonist Drugs Revenue Market Share by Country in 2021

Figure 62. Egypt Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 63. South Africa Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 64. Israel Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 65. Turkey Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 66. GCC Country Opioids Agonist Drugs Revenue Growth 2017-2022 ($ Millions)

Figure 67. Manufacturing Cost Structure Analysis of Opioids Agonist Drugs in 2021

Figure 68. Manufacturing Process Analysis of Opioids Agonist Drugs

Figure 69. Industry Chain Structure of Opioids Agonist Drugs

Figure 70. Channels of Distribution

Figure 71. Distributors Profiles